周围血液中的RNA修饰与急性冠状动脉综合征有关
Miron Sopic1,2, Victoria Stopa2, Jelena Munjas1
1Department of Medical Biochemistry, Faculty of Pharmacy University of Belgrade, Serbia.
Journal of molecular and cellular cardiology plus
|March 12, 2026
概括
急性冠状动脉综合征 (ACS) 与RNA修饰的显著变化有关,特别是N6,2'-O-dimethyladenosine (m6Am) 的减少. 这一发现确定了m6Am作为心肌梗塞的潜在独立生物标志物.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 心脏病学 心脏病学
背景情况:
- 急性冠状动脉综合征 (ACS) 涉及炎症反应,但它们对RNA修饰的影响尚不清楚.
- 研究ACS患者的表皮转录变化可以揭示对疾病机制的新见解.
研究的目的:
- 研究患有不同ACS亚型的患者外周血液单核细胞 (PBMC) 的全球表皮转录学模式.
- 为了确定与ACS和心肌梗塞的严重程度相关的特定RNA修饰.
主要方法:
- 量化了五种RNA修饰 (m1A,2敏度-O-mA,m6A,m6Am, Ψ) 和它们在PBMC中的比例,这些患者患有ST升高心肌梗塞 (STEMI),非ST升高心肌梗塞 (NSTEMI),不稳定的胸痛 (UAP) 和稳定的胸痛 (SAP),使用液态染色体质谱.
- 分析了不同患者组的RNA修饰水平和比率的差异.
- 与临床标记 (hsCRP,hsTnI) 相关联的RNA修饰水平,并使用多变量逻辑回归评估了它们与STEMI的独立关联.
主要成果:
- 与稳定性胸痛 (SAP) 相比,STEMI患者的2尖度-O-mA,m6Am和 Ψ水平显著降低.
- 在UAP和NSTEMI患者中,m6Am也降低了,这表明m6Am在ACS严重程度上下降的趋势.
- 降低的m6Am水平与高灵敏度C反应蛋白 (hsCRP) 和高灵敏度托波宁I (hsTnI) 相反相关,m6Am被确定为STEMI的独立预测因子.
结论:
- ACS与RNA修饰的选择性改变有关,特别是m6Am的减少.
- N6,2敏度-O-二甲基氨酸 (m6Am) 作为与心肌梗塞相关的独立表皮转录体标志物.
- 这些发现突显了表体转录学在理解ACS病变发生和识别新生物标志物的潜力.
相关概念视频
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
611
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
611
01:30Acute Coronary Syndrome III: Diagnostic Studies
362
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
362
01:30Acute Coronary Syndrome I: Introduction
1.4K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.4K
01:26Coronary Artery Disease II: Pathophysiology
862
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
862
01:30Coronary Artery Disease I: Introduction
1.4K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.4K
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
682
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
682